Krakow, Poland – 20 April 2017 – Selvita, one of the largest drug discovery companies in Europe, has published annual financial results demonstrating its continued dynamic business performance across all segments.
Net sales revenue in 2016 (excl. grants) amounted to PLN 48.1 MM, reflecting 17% growth compared with 2015, when net sales revenue amounted to PLN 41.0 MM. This net sales revenue in 2016, does not include the profit from Nodthera Ltd. share acquisition totaling PLN 6.1 MM which is presented in “other operating profits” line.
Revenues from the services segment in 2016 totaled PLN 32.4 MM, which represents growth of over 40% in comparison to the same period of the previous year when these revenues amounted to PLN 24.1 MM.
Selvita’s innovation segment generated in 2016 revenues amounting to PLN 18.4 MM (incl. profit from Nodthera Ltd.), reflecting 19% dynamics compared with 2015 when the revenues amounted to PLN 15.4 MM.
2016 is the first financial year of Ardigen S.A. operations. Ardigen S.A. is Selvita’s subsidiary where an organized part of the enterprise (the Group’s bioinformatics division) was contributed in 2015. This bioinformatics segment of the Group generated in 2016 the revenue in the amount of PLN 3.4 MM, reflecting 34% growth compared with revenue of the bioinformatics division in 2015 when it totaled PLN 2.6 MM.
The total operating revenues (incl. grants) in 2016 amounted to PLN 66.3 MM, representing a solid 19% business growth, as compared to 2015 when the total revenues amounted to PLN 55.7 MM.
The value of the 2017 contracts portfolio resulting from commercial contracts and grant agreements signed as of the publication date of this report (backlog) amounts to PLN 80 MM, and is 127% higher than the backlog reported in March 2016.
The results show clearly that the company is growing strong across all divisions, enjoying continuous revenue growth.
The net profit of Selvita Group in 2016 amounted to PLN 4.6 MM (excl. non-cash costs of the current stock option program).
The simplified version of the Selvita Consolidated Annual Report for 2016 is available at: https://selvita.com/investor-relations/stock-market-reports/. The full version (In Polish) is available at: https://selvita.com/pl/centrum-inwestora/raporty-gieldowe/